Dr. Sofia Bartlett is a postdoctoral research fellow in the clinical prevention services division at the British Columbia Centre for Disease Control and Department of Pathology and Laboratory Medicine at the University of British Columbia. She obtained her Doctorate degree (PhD) in Molecular Epidemiology at the Kirby Institute, University of New South Wales in Sydney, Australia. Her research focusses on improving the health of marginalised populations, such as people who inject drugs and people living with hepatitis C infection. Sofia’s research utilizes a multidisciplinary approach, combining molecular genetics, bioinformatics and clinical epidemiology, and she is currently working on applying syndemic theory to understand factors related to gaps in the care cascade for hepatitis C infection in British Columbia.


Dr. Zahid Ahmad Butt is a medical doctor and infectious disease epidemiologist with a PhD in Epidemiology from Michigan State University and a Masters of Science (MSc) degree in Epidemiology & Biostatistics from Aga Khan University. He has extensive experience in the implementation, monitoring and evaluation of nationwide immunization and infectious disease surveillance programs in developing countries. He has also been instrumental in the development of various Public Health programs internationally. He has over 15 years of public health experience and has worked with a number of organizations most notably WHO and UNICEF in their immunization programs.

A Fulbright scholar, Dr. Zahid is currently a Post Doctoral Research Fellow at the School of Population and Public Health at the University of British Columbia. His research interests are HIV/HCV/HBV coinfections, vaccine preventable diseases, communicable and non-communicable disease syndemics, global health and spatial analysis of complex data. Currently based at BCCDC, his research examines the inter-relationships between syndemics of HIV and Hepatitis B & C, social disparities, co-morbidities and substance use.


m-darvishian_photoDr. Maryam Darvishian is a postdoctoral research fellow in the clinical prevention services division at the BC Centre for Disease Control (BCCDC) and School of Population and Public Health, University of British Columbia. She obtained her Master of Science degree (MSc) in Clinical and Psychosocial Epidemiology and Doctorate degree (PhD) in Epidemiology/Pharmaco-Epidemiology at University Medical Center Groningen (UMCG), Netherlands. At BCCDC her research focuses on hepatitis C treatments effectiveness and disease outcomes. Her research interest includes epidemiology and pharmaco-epidemiology of infectious diseases, real-world treatment effectiveness and bias-adjustment techniques in observational study designs.


Dr. Margo Pearce is a CIHR Health Systems Impact Fellowship-supported postdoctoral fellow in the clinical prevention division at BC Centre for Disease Control and UBC School of Population and Public Health (SPPH). She completed her MPP at Simon Fraser University, her MSc at the London School of Hygiene and Tropical Medicine, and her PhD at UBC SPPH. In addition, she completed a postdoctoral fellowship with the Canadian HIV Trials Network. Margo's research interests include Indigenous people's health and wellness; adversity, resilience, and health over the life course; and healing-centred health policies and systems. Her current postdoctoral research at BCCDC is in partnership with the First Nations Health Authority. This work seeks to: 1) identify systemic deficiencies in the provision of HCV care to First Nations in BC, and 2) apply a strengths and wellness-based perspective to First Nations people’s experiences within the HCV cascade of care.

Dr. Carmine Rossi is a CanHepC-supported postdoctoral research fellow in the viral hepatitis division at the British Columbia Centre for Disease Control. He completed his MSc and PhD in Epidemiology at McGill University in Montreal, Canada. His research interests include HCV treatment uptake in the area of direct-acting antivirals, risk factors for HCV re-infection after successful treatment, extrahepatic manifestations associated with chronic infection, and health-care service utilization among key populations, including injection drug users, immigrants and aboriginals. His methodologic interests include the analysis of complex longitudinal data, the use of time-to-event models, and the incorporation of administrative data-linkages to answer public health questions.